ArticleDisease markers2015

Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.

Massimiliano Castellazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.